Fisher Adam C, DeLisa Matthew P
School of Chemical and Biomolecular Engineering Cornell University, Ithaca, NY 14853, USA.
J Mol Biol. 2009 Jan 9;385(1):299-311. doi: 10.1016/j.jmb.2008.10.051. Epub 2008 Nov 1.
One of the most commonly used recombinant antibody formats is the single-chain variable fragment (scFv) that consists of the antibody variable heavy chain connected to the variable light chain by a flexible linker. Since disulfide bonds are often necessary for scFv folding, it can be challenging to express scFvs in the reducing environment of the cytosol. Thus, we sought to develop a method for antigen-independent selection of scFvs that are stable in the reducing cytosol of bacteria. To this end, we applied a recently developed genetic selection for protein folding and solubility based on the quality control feature of the Escherichia coli twin-arginine translocation (Tat) pathway. This selection employs a tripartite sandwich fusion of a protein-of-interest with an N-terminal Tat-specific signal peptide and C-terminal TEM1 beta-lactamase, thereby coupling antibiotic resistance with Tat pathway export. Here, we adapted this assay to develop intrabody selection after Tat export (ISELATE), a high-throughput selection strategy for the identification of solubility-enhanced scFv sequences. Using ISELATE for three rounds of laboratory evolution, it was possible to evolve a soluble scFv from an insoluble parental sequence. We show also that ISELATE enables focusing of an scFv library in soluble sequence space before functional screening and thus can be used to increase the likelihood of finding functional intrabodies. Finally, the technique was used to screen a large repertoire of naïve scFvs for clones that conferred significant levels of soluble accumulation. Our results reveal that the Tat quality control mechanism can be harnessed for molecular evolution of scFvs that are soluble in the reducing cytoplasm of E. coli.
最常用的重组抗体形式之一是单链可变片段(scFv),它由通过柔性接头连接到可变轻链的抗体可变重链组成。由于二硫键对于scFv折叠通常是必需的,因此在胞质溶胶的还原环境中表达scFv可能具有挑战性。因此,我们试图开发一种方法,用于在细菌的还原胞质溶胶中稳定存在的scFv的抗原非依赖性选择。为此,我们基于大肠杆菌双精氨酸转运(Tat)途径的质量控制特征,应用了最近开发的用于蛋白质折叠和溶解性的遗传选择。这种选择采用了感兴趣的蛋白质与N端Tat特异性信号肽和C端TEM1β-内酰胺酶的三方夹心融合,从而将抗生素抗性与Tat途径输出耦合。在这里,我们对该检测方法进行了改进,以开发Tat输出后体内抗体选择(ISELATE),这是一种用于鉴定溶解性增强的scFv序列的高通量选择策略。使用ISELATE进行三轮实验室进化,有可能从不溶性亲本序列进化出可溶性scFv。我们还表明,ISELATE能够在功能筛选之前将scFv文库聚焦在可溶性序列空间中,因此可用于增加找到功能性体内抗体的可能性。最后,该技术用于筛选大量未经筛选的scFv,以寻找具有显著可溶性积累水平的克隆。我们的结果表明,Tat质量控制机制可用于scFv的分子进化,这些scFv可溶于大肠杆菌的还原细胞质中。